Antibody Markers in Predicting Type 1 Diabetes: A Review

Dupre J. , Stiller C.R. Summary and critical evaluation of immunosuppression in recent onset of type I diabetes. In: Andreani D. , Kolb H. , Pozzilli P. , eds. Immunotherapy of type 1 diabetes. Chichester: John Wiley, 1989: 125–36

Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes. Diabetes 1965; 14: 619–33

Koevary S. , Rossini A. , Stoller W. , Chick W. , Williams R.M. Passive transfer of diabetes in the BB/W rat. Science 1983; 220: 727–9

Sibley R.K. , Sutherland D.E.R. , Goetz F. , Michael A.F. Recurrent diabetes mellitus in the pancreas of iso and allografts. Lab Invest 1985; 53: 132–5

Doniach J. , Morgan A.G. Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol 1973; 2: 233–37

Junker K. , Egeberg J. , Kromann H. , Nerup J. An autopsy study of the islets of Langerhans in acute juvenile diabetes mellitus. Acta Pathol Microbiol Scand Sect A 1977; 85: 699–704

Ogilvie R.F. The endocrine pancreas in human and experimental studies. In: Cameron M.P. , O'Connor M. , eds. Ciba Foundation colloquia on endocrinology. The aetiology of diabetes mellitus and its complications. London: Churchill, 1964; 15: 49–64

Hanafusa T. , Miyazaki A. , Miyagawa J. Immunohistochemical analysis of biopsied pancreas in newly diagnosed IDDM patients. Diabetes Res Clin Prac 1988; 5(Suppl 1): S132

Mandrup-Poulsen T. , Helqvist S. , Molvig J. , Wogensen L.D. , Nerup J. Cytokines as immuno effector molecules in autoimmune endocrine diseases with special reference to insulin dependent diabetes mellitus. Autoimmunity 1989; 4: 191–218

Wilkin T.J. Autoimmunity: Attack or defence? Autoimmunity 1989; 3: 57–73

Adams D.D. , Purves H.D. Abnormal responses in the assay of thyrotrophin. Univ Otago Med School Proc 1956; 36: 11–12

Steel N.R. , Taylor J.J. , Holcombe M. Antibodies that block stimulation by TSH or TSAB of thyroid hormone section in primary hypothyroidism. Autoimmunity 1988; 1: 81–90

Wulfraat N.M. Adrenal autoimmunity: immunoglobulins affecting adrenal growth and steroidogenesis. Amsterdam: Free University Press, 1987

Wilkin T.J. , Hammonds P. , Mirza I. , Bone A.J. , Webster K.A. Graves' disease of the beta cell: glucose dysregulation due to islet cell stimulating antibodies. Lancet 1988; 2: 1155–8

Webster K.A. , Bone A.J. , Wilkin T.J. Islet cell blocking antibodies: A novel basis for type 1 diabetes? Diabetic Med 1989; 6(Suppl 1): A5

Bottazzo G.F. , Florin-Christensen A. , Doniach D. Islet cell anitbodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; ii: 1279–83

MacCuish A.C. , Jordan J. , Campbell C.J. , Duncan L.J.P. , Irvine W.J. Antibodies to islet cell in insulin dependent diabetics with co-existent autoimmune disease. Lancet 1974; ii: 1529–33

Baekkeskov S. , Nielsen J.H. , Marner B. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167–9

Van de Winkel M. , Smets G. , Gepts W. , Pipeleers D. Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells. J Clin Invest 1982; 70: 41–9

Palmer J.P. , Asplin C.M. , Clemons P. Insulin antibodies in insulin dependent diabetes before insulin treatment. Science 1983; 222: 1337–9

Wilkin T.J. , Nicholson S. Autoantibodies against human insulin. BMJ 1984; 288: 349–52

Triolo G. , Giadina E. , Rinaldi A. , Sedio G. , Bompiani G.D. Autoantibodies to human albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes. J Clin Lab Immunol 1986; 21: 113–17

Di Mario U. , Dotta F. , Crisa L. Circulating antiimmunoglobulin antibodies in recent onset type I diabetic patients. Diabetes 1988; 37: 462–6

Dotta F. , Wicker L. , Peterson A. Inheritance of anti-‘polar’ antibodies in NOD mice: evidence for a single recessive gene. Diabetes 1989; 38(Suppl 2): 71A

Lendrum R. , Walker G.J. , Cudworth A.G. Islet cell antibodies in diabetes mellitus. Lancet 1976; ii: 1273–7

Boitard C. , Bonifacio E. , Bottazzo G.F. , Gleichmann H. , Molenaar J. Immunology and diabetes workshops: report on the third international (stage 3) workshop on the standardisations of cytoplasmic islet cell antibodies. Diabetologia 1988; 31: 451–2

Tarn A.C. , Thomas J.N. , Dean B.M. Predicting insulin dependent diabetes. Lancet 1988; i: 845–50

Irvine W.J. , Sawers J.S.A. , Feek C.M. , Prescott R.J. , Duncan L.J.P. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemia agent therapy in diabetes mellitus. J Clin Lab Immunol 1979; 2: 23–6

Jackson R.A. , Soeldner J.S. , Eisenbarth G.S. Predicting insulin dependent diabetes. Lancet 1988; ii: 627

Johnstone C. , Millward B.A. , Hoskins P. Islet cell antibodies as predictors of the later development of type I (insulin dependent) diabetes. A study in identical twins. Diabetologia 1989; 32: 382

McCulloch D.K. , Claff L.J. , Shoenfeld S.L. Subclinical beta cell dysfunction is not always progressive among first degree relatives of type I diabetes: five year follow-up of the Seattle study. Diabetes 1988; 38(Suppl 2): 90A

Dahlquist G. , Blom L. , Tuvemo T. The Swedish childhood diabetes study - results from a nine year case register and a one year case referrent study indicating that IDDM is associated with NIDDM and autoimmune disorders. Diabetologia 1989; 32: 2–6

Rotter J.I. , Rimoin D.L. The genetics of diabetes. Hosp Pract 1987; 22: 79–87

Landin-Olsen M. , Carlsson A. , Dalqvist G. Islet cell and other organ specific autoantibodies in all children developing type I (insulin dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989; 32: 387–95

Maclaren N. , Riley W. , Silverstein J. , Schatz D. , Atkinson M. Progress towards the prevention of insulin dependent diabetes: The Gainesville studies. In: Andreani D. , Kolb H. , Pozzilli P. , eds. Immunotherapy of type I diabetes. Chichester: John Wiley, 1989: 147–54

Vardi P. , Dib S.A. , Tuppleman M. Competitive insulin autoantibody assay: Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 1987; 36: 1286–91

Wilkin T.J. , Nicholson S. , Casey C. A microenzyme linked immunosorbent assay for insulin antibodies in serum. J Immunol Methods 1985; 76: 185–94

Wilkin T.J. The measurement of insulin antibodies and its interpretation. In: Pal S.B. , ed. Immunoassay technology, vol. 2, Berlin: Walter de Gruyter, 1986: 17–56

Wilkin T.J. , Shoenfeld S.L. , Diaz J-L Systematic variation and differences in insulin autoantibody measurement. Diabetes 1989; 8: 172–81

Hirata Y. , Ishizu H. , Ouchi N. Insulin autoimmunity in a case of spontaneous hypoglycaemia. J Japan Diabetic Soc 1970; 13: 312–20

Blackshear P. , Rotner H. , Kriancuinask K. , Kahn C.R. Reactive hypoglycaemia and insulin autoantibodies in drug induced lupus erythematosus. Ann Intern Med 1983; 99: 182–4

Karjalainen J. , Salmela P. , Ilonen J. A comparison of childhood and adult type 1 diabetes. N Engl J Med 1989; 320: 881–6

Soeldner J.S. , Tuttleman M. , Srikanta S. , Ganda O.P. , Eisenbarth G.S. Insulin-dependent diabetes mellitus and autoimmunity: islet cell antibodies, insulin autoantibodies and B cell failure. N Engl J Med 1985; 313: 393–4

Srikanta S. , Ricker A.T. , McCulloch D.K. Autoimmunity to insulin, beta cell dysfunction and development of insulin-dependent diabetes. Diabetes 1986; 35: 139–42

Dean B.M. , Becker F. , McNally J.M. Insulin autoantibodies in the prediabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 1986; 29: 339–42

Atkinson M.A. , Maclaren N.K. , Riley W.J. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 1987; 35: 894–8

Betterle C. , Predsotto F. , Pedini B. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for development of type 1 (insulin-dependent) diabetes. A 10 year follow-up study. Diabetologia 1987; 30: 292–7

Ziegler A.G. , Ziegler R. , Jackson R.A. , Eisenbarth G.S. Testing the linear destruction hypothesis in type 1 diabetes: the Joslin study. In: Andreani D. , Kolb H. , Pozzilli P. , eds. Immunotherapy of type 1 diabetes. Chichester: John Wiley, 1989: 155–67

Wilkin T.J. , Mirza I. , Armitage M. , Casey C.R. , Scott-Morgan L. Insulin autoantibody polymorphisms with greater discrimination for diabetes in humans. Diabetologia 1988; 31: 670–4

Baekkeskov S. , Landin M. , Christensen J.K. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin dependent diabetes. J Clin Invest 1987; 79: 926–30

Colman P.G. , Campbell I.L. , Kay T.W.J. , Harrison L.C. 64,000 Mr autoantigen in type 1 diabetes. Evidence against its surface location on human islets. Diabetes 1987; 36: 1432